Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression

Weibo Luo, Ryan Chang, Jun Zhong, Akhilesh Pandey, Gregg L. Semenza

Research output: Contribution to journalArticlepeer-review

141 Scopus citations

Fingerprint

Dive into the research topics of 'Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression'. Together they form a unique fingerprint.

Medicine & Life Sciences